Results 51 to 60 of about 1,421,260 (161)

Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals: A randomized trial

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In adults with moderate AD post‐TCS and ‐TCI, who may otherwise be eligible for systemic therapy, 1.5% ruxolitinib cream improved clinical signs and symptoms in the TRuE‐AD4 study. Abstract Background In patients with moderate atopic dermatitis (AD), topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI) often do not sufficiently ...
José Manuel Carrascosa   +14 more
wiley   +1 more source

Ultrasound evaluation of peripheral neuropathy in POEMS syndrome

open access: yes, 2011
Introduction: Polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes (POEMS) syndrome is a rare multisystem disorder associated with plasma cell dyscrasia whose main neurological feature is a demyelinating polyneuropathy.
LUCCHETTA, MARTA   +12 more
core   +1 more source

Clinicogenetic Characterization of H Syndrome in a South African Child

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT H syndrome is a rare autosomal recessive genodermatosis caused by loss‐of‐function SLC29A3 variants, combining hyperpigmented indurated plaques and hypertrichosis with life‐threatening autoinflammation. We report a 5‐year‐old South African girl of first‐cousin parents who presented with hyperinflammation mimicking macrophage activation ...
Tshimogo Tswelopele Sathekge   +1 more
wiley   +1 more source

Clinical and electrophysiological profiles in early recognition of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome

open access: yesChinese Medical Journal, 2019
. Background:. The detection of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome at early stage is challenging for neurologists.
Qin Wang   +7 more
doaj   +1 more source

Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objectives To review the evidence base, evolution, outcomes, adverse events (AEs), and management for third‐space endoscopy (TSE) procedures for management of benign motility disorders. Methods This review examines TSE procedures for motility disorders, reviewing the current available techniques, success, outcomes, and long‐term outcomes from ...
Sanjana Bhagwat, Amol Bapaye
wiley   +1 more source

Síndrome de POEMS Poems syndrome

open access: yesRevista Cubana de Medicina, 2013
El síndrome de POEMS es un trastorno paraneoplásico asociado a discrasia de células plasmáticas que reúne, entre sus criterios diagnósticos mayores, la presencia de polineuropatía y de gammapatía monoclonal, entre otras como esclerosis ósea y/o cutánea ...
Karen Valdés Álvarez   +2 more
doaj  

Pulmonary hypertension in POEMS syndrome

open access: yesHaematologica, 2013
POEMS syndrome is a rare clonal plasma cell disease. Patients with POEMS syndrome are at risk of developing pulmonary hypertension, but the data on its incidence and impact on outcome are limited.
Jian Li   +7 more
doaj   +1 more source

Lumps, Bumps, and Diagnostic Stumps: A Case Report of IgG4‐Related Disease

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT IgG4‐related disease and idiopathic multicentric Castleman disease are rare conditions that can present with overlapping features, complicating diagnosis and delaying proper treatment.
Michael Miller   +4 more
wiley   +1 more source

POEMS syndrome: clinical update [PDF]

open access: yes, 2019
POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes) is a rare paraneoplastic syndrome, caused by a plasma cell proliferative disorder, which is most commonly lambda restricted. The neurological hallmark, which forms one
Ginsberg, L, Brown, R
core   +1 more source

Autism Screening in the First Year and Beyond: Comparison of Multiple Measures

open access: yesAutism Research, Volume 19, Issue 10, October 2026.
ABSTRACT Autism screening aids in early detection and diagnosis. Several screeners are available for toddlers 16 months and older, but there is little data on the accuracy of screening measures used in the first year of life. A community sample (N = 1641) completed three screeners—M‐CHAT‐R, ITC, VIRSA—online at 6, 9, 12, 18, and 24 months of age ...
Devon N. Gangi   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy